-

Abiomed to Present at Upcoming Investor Conferences

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at William Blair’s 41st Annual Growth Stock Conference (virtual) on Tuesday, June 1st at 4:40pm CT and the Jefferies Virtual Healthcare Conference on Thursday, June 3rd at 2:00pm ET.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, including with respect to Abiomed's development of existing and new products, the Company's commercial growth, future business opportunities and pending regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements due to a number of factors, including uncertainties related to the scope, extent and duration of the impact of the COVID-19 pandemic, development, testing and related regulatory approvals, including the possibility of future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological changes, governmental requirements, litigation, future capital requirements and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent filings with the SEC. Readers of this press release are advised not to evaluate forward-looking statements, which reflect information available only as of the date of this release, as reliable information. The Company is under no obligation to release updates to these forward-looking statements to reflect events or circumstances occurring after the date of the release or as a result of the impact of unforeseen events.

Contacts

Todd Trapp
Vice President and Chief Financial Officer
978-646-1680
ttrapp@abiomed.com

Sarah Lima
Communications Manager
978-882-8211
slima@abiomed.com

Abiomed, Inc.

NASDAQ:ABMD

Release Summary
Abiomed to present at William Blair’s 41st Annual Growth Stock Conference and the Jefferies Virtual Healthcare Conference.
Release Versions

Contacts

Todd Trapp
Vice President and Chief Financial Officer
978-646-1680
ttrapp@abiomed.com

Sarah Lima
Communications Manager
978-882-8211
slima@abiomed.com

More News From Abiomed, Inc.

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed Announces First Patients Enrolled in FDA Pivotal Trial for Impella ECP, World’s Smallest Heart Pump...

First Patients in the World Treated with Impella RP Flex with SmartAssist

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist....

Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed today announces financial results for the quarter ended September 30, 2022....
Back to Newsroom